Cancer Genetics (CGIX) Sees IPO Price in $11-$13/Share Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cancer Genetics (CGIX) Adjusts Expected IPO Price to $10 - $12/Share
March 4, 2013 10:35 AM ESTCancer Genetics (Nasdaq: CGIX) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The company plans to sell 1.85 million shares and sees an offering price of $10 to $12 per share. Prior expectations from the... More
